Weight Loss Drug Linked to Blindness Risk
2024-12-17
Two new studies show that long-term use of antidiabetic drug semaglutide, sold under brand names Ozempic and Wegovy among others, increase the risk of blindness.
Two new studies show that long-term use of antidiabetic drug semaglutide, sold under brand names Ozempic and Wegovy among others, increase the risk of blindness.
German Chancellor Olaf Scholz’s visit to Beijing last week may be the opening move in an effort to replace the US with China as a key ally and trade partner.Continue Reading
A new book shows the overwhelming similarities between Charles Darwin’s On the Origin of Species and an earlier work by the naturalist Patrick Matthew. The new book Science Fraud by Dr. Mike Sutton is published this coming Saturday.Continue Reading
© 2024 Gilbert House